Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000453950

Medchemexpress LLC Isoxazole | 288-14-2 | 100.0% | 69.06 | 1 ML
SDP

Catalog No. 5000453950
Encompass_Preferred

Isoxazole is a five-membered heterocycle drug scaffold that has been used as a BET bromodomain inhibitor and can improve β-cell function in a diabetic mouse model. Its derivatives show broad biological activities, including antimicrobial, antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, immunomodulatory, analgesic, anti-tuberculosis, and anti-diabetic effects.

  • Broad biological activities: Isoxazole and its derivatives exhibit a wide range of biological activities.
  • BET bromodomain inhibitor: It has been used as a BET bromodomain inhibitor.
  • Improved β-cell function: It can improve β-cell function in a diabetic mouse model.
  • HSP90 inhibitor: Bicyclic Isoxazole can act as an HSP90 inhibitor.
  • Selective multidrug resistance protein (MRP1) inhibitor: Tricyclic Isoxazole shows promise as a selective MRP1 inhibitor.

Catalog No. 50-004-53950 Supplier Medchemexpress LLC Supplier No. HYW01064910MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Isoxazole is a five-membered heterocycle drug scaffold that has been used as a BET bromodomain inhibitor and can improve β-cell function in a diabetic mouse model. Its derivatives show broad biological activities, including antimicrobial, antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, immunomodulatory, analgesic, anti-tuberculosis, and anti-diabetic effects.

  • Broad biological activities: Isoxazole and its derivatives exhibit a wide range of biological activities.
  • BET bromodomain inhibitor: It has been used as a BET bromodomain inhibitor.
  • Improved β-cell function: It can improve β-cell function in a diabetic mouse model.
  • HSP90 inhibitor: Bicyclic Isoxazole can act as an HSP90 inhibitor.
  • Selective multidrug resistance protein (MRP1) inhibitor: Tricyclic Isoxazole shows promise as a selective MRP1 inhibitor.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.